TB Alliance is a global organization based in New York, NY that is dedicated to developing new drugs and transforming the way tuberculosis (TB) drugs are developed. With a focus on addressing the global pandemic of TB, TB Alliance aims to provide more effective and accessible treatments to those in need, with a mission to reduce the cycle of poverty and improve maternal and child health. Through their innovative research and development efforts, TB Alliance manages the largest pipeline of new TB drugs in history, offering new hope in the fight against this deadly disease.
With a strong commitment to improving access to TB treatments, TB Alliance works towards delivering new drugs to those who need them most. Recognizing the limitations of current TB drug regimens, TB Alliance strives to develop faster, more effective, and child-friendly medicines that can help combat the global TB crisis. By collaborating with communities, engaging in operational research, and advocating for stronger investments, TB Alliance aims to transform TB treatment and make a significant impact in the fight against this devastating disease.
Generated from the website